. Treatment with extracorporeal membrane oxygenation may be required for many patients with influenza A (H1N1). JAMA. 2009;302(17).
One-third of young adult patients in Australia and New Zealand may have received extracorporeal membrane oxygenation to treat respiratory failure associated with influenza A (H1N1), according to findings published recently.
There was a 21% mortality rate among these patients who had severe hypoxemia.
Researchers conducted an observational study of 68 patients with influenza-associated acute respiratory distress syndrome in Australia and New Zealand between June 1 and Aug. 31, 2009. All patients in the study group had received extracorporeal membrane oxygenation treatment. There were 61 cases of either confirmed 2009 influenza A(H1N1) (n=53) or influenza A which was not subtyped (n=8).
The aim of the study was to determine the incidence, clinical features, degree of pulmonary dysfunction, technical characteristics, duration of extracorporeal membrane oxygenation, complications and survival.
Prior to oxygenation treatment, the studied patients had severe respiratory failure despite advanced mechanical ventilatory support with a median Pao2/fraction of inspired oxygen (FIo2) ratio of 56 (48-63), positive end-expiratory pressure of 18 (15-20) cm H2O and an acute lung injury score of 3.8 (3.5-4.0).
The median duration of oxygenation support was 10 (7-15) days.
Survival to ICU discharge was reported among 71% (n=48; 95% CI, 60%-82%) of patients. Of those 48 patients, 32 survived to hospital discharge and 16 remained as hospital inpatients.
There were 14 deaths, representing 21% of the study population (95% CI, 11%-30%). Six patients remained in the ICU; two of those patients remained on extracorporeal oxygenation treatment.
See Also:
Latest articles in those days:
- [preprint] Potential Pathways of Spread of Highly Pathogenic Avian Influenza A/H5N1 Clade 2.3.4.4b Across Dairy Farms in the United States 10 hours ago
- [preprint] The avian and human influenza A virus receptors sialic acid (SA)-α2,3 and SA-α2,6 are widely expressed in the bovine mammary gland 10 hours ago
- Repeatability and reproducibility of hunter-harvest sampling for avian influenza virus surveillance in Great Britain 11 hours ago
- The RBPome of influenza A virus NP-mRNA reveals a role for TDP-43 in viral replication 11 hours ago
- Novel Genotype of HA Clade 2.3.4.4b H5N8 Subtype High Pathogenicity Avian Influenza Virus Emerged at a Wintering Site of Migratory Birds in Japan, 2021/22 Winter 11 hours ago
[Go Top] [Close Window]